Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Recruiting · NCT05183035 · Registry updated 2026-08-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2026-08-24 | NCT05183035 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AbbVie | 340 |
| EuPAL | 1 |
| PedAL BCU, LLC | 3 |
| Princess Maxima Center for Pediatric Oncology (European Sponsor) | 1 |
| Roche-Genentech | 11 |
90 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.